# Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients

Study · id `cardio:ct-nct02448342` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02448342](<https://clinicaltrials.gov/study/NCT02448342>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02448342

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 380 participants.

## Technical summary

Registry record NCT02448342. Randomized; no masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2017-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 380 participants (planned count; ClinicalTrials.gov record NCT02448342, source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)
- Started: 2015-09 (actual) (ClinicalTrials.gov record NCT02448342, source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)
- Primary completion: 2017-11-30 (actual) (ClinicalTrials.gov record NCT02448342, source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)
- Completion: 2017-11-30 (actual) (ClinicalTrials.gov record NCT02448342, source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02448342, source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02448342-2017-12-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
- Acronym: SMILE™
- Condition: Heart Failure
- Intervention (Device): Remote Dielectric Sensing (ReDS) Wearable System
- Lead sponsor: Sensible Medical Innovations Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 5852ecad88fb290502cb8c13eea8128aabe28535cb07955ada0d72da1e63e4ba
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
